News

HP and Tecan Launch Combined Single-Cell and Reagent Dispenser, Report 40x Faster Dosing for Drug Discovery

HP and Tecan have launched the Duo Digital Dispenser, a system that combines single-cell isolation and reagent dispensing in one …

Continue ›››

Experity Rolls Out AI-Integrated Partner Ecosystem to Streamline Urgent Care Operations

Experity has launched a Partner Ecosystem aimed at integrating AI-based tools into urgent care operations. The initiative, announced this week, …

Continue ›››

AI Model Reconstructs 3D Human Faces from DNA with High Accuracy

A new study has introduced Difface, an AI-based framework capable of reconstructing 3D human facial images directly from DNA, demonstrating …

Continue ›››

Boehringer Ingelheim Taps Tempus’ AI and Patient Data to Deepen Cancer Research Pipeline

Tempus has entered a strategic multi-year collaboration with Boehringer Ingelheim to support the expansion of Boehringer’s oncology pipeline using AI …

Continue ›››

Regeneron Acquires 23andMe Assets for $256M to Expand Consumer Genomics and Data-Driven Drug Discovery

Regeneron has announced an agreement to acquire substantially all assets of 23andMe for $256 million, following a bankruptcy auction process. …

Continue ›››

Oracle Rebuilds Its EHR Infrastructure to Support AI-Native Workflows

Oracle has launched a new electronic health record (EHR) platform that diverges entirely from the architecture of Cerner, which it …

Continue ›››

CRISPR Therapy Saves Infant With Rare Genetic Disorder

Doctors at Children’s Hospital of Philadelphia have reported a breakthrough use of CRISPR gene editing to treat an infant with …

Continue ›››

Researchers Use Terahertz Imaging for First-Ever 3D View of Cochlea Without Surgery

In a study published March 27 in Optica, researchers from Waseda, Kobe, and Osaka Universities reported the successful use of …

Continue ›››

Medable Updates Digital Platform With Oncology-Focused Tools Ahead of ASCO 2025

Medable has announced the release of a new version of its digital clinical trials platform tailored specifically for oncology, ahead …

Continue ›››

Absci Doses First Participants in Phase 1 Trial of AI-Designed Antibody for IBD

Absci has announced the dosing of the first participants in a Phase 1 trial of ABS-101, an investigational antibody for …

Continue ›››

Eligo Bioscience Gets $5M Grant to Advance Gene-Editing Skin Therapy Using Bacteria

The funding supports development of Eligo’s topical gene delivery system, which programs skin-resident bacteria to locally produce therapeutic biologics.

Continue ›››

Kvantify Taps Gefion AI Supercomputer to Scale Quantum Chemistry Simulations for Drug Discovery

As reported by The Quantum Insider, Kvantify, a Denmark-based quantum software firm focused on chemistry and drug discovery, has become …

Continue ›››